Illumina, Inc. Announces Scale-Up of its Genome Analyzer Sequencing Technology at The Broad Institute of MIT and Harvard

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that the Broad Institute of MIT and Harvard has acquired 22 additional Genome Analyzers to increase its installed base of the Illumina sequencing platform to 47 units.